AGREEMENT AND PLAN OF MERGER by and among NEUROBO PHARMACEUTICALS, INC., SHELBY MERGER SUB 1, INC., SHELBY MERGER SUB 2, LLC, ANA THERAPEUTICS, INC. and AKASH BAKSHI, solely in his capacity as Stockholder Representative (for the limited purposes...Agreement and Plan of Merger • January 6th, 2021 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of December 31, 2020, by and among NEUROBO PHARMACEUTICALS, INC., a Delaware corporation (“Parent”), SHELBY MERGER SUB 1, INC., a Delaware corporation (“First Merger Sub”), SHELBY MERGER SUB 2, LLC, a Delaware limited liability company (“Second Merger Sub” and together with First Merger Sub, “Merger Subs”), ANA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and AKASH BAKSHI, solely in his capacity as representative of the Stakeholders (as defined below) (the “Stockholder Representative”).
NEUROBO PHARMACEUTICALS, INC. SUPPORT AGREEMENTSupport Agreement • January 6th, 2021 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SUPPORT AGREEMENT (this “Agreement”), dated as of December 31, 2020 (the “Effective Date”), is made by and among NeuroBo Pharmaceuticals, Inc., a Delaware corporation (“Parent”), ANA Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned holder (“Stockholder”) of shares of capital stock (the “Shares”) of Parent. Capitalized terms used but not defined in this Agreement shall have the meaning set forth in the Merger Agreement (as defined below).
LOCK-UP AGREEMENTLock-Up Agreement • January 6th, 2021 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
